liarozole has been researched along with abiraterone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosaka, M; Takeda, M | 1 |
| Leroux, F | 1 |
2 review(s) available for liarozole and abiraterone
| Article | Year |
|---|---|
[Inhibitors of the key enzymes of androgen synthesis: potential agents as targets for prostate cancer].
Topics: 17-Hydroxysteroid Dehydrogenases; Androgen Antagonists; Androstenes; Androstenols; Animals; Antineoplastic Agents, Hormonal; Carbazoles; Enzyme Inhibitors; Humans; Imidazoles; Ketoconazole; Male; Prostatic Neoplasms; Steroid 17-alpha-Hydroxylase; Testosterone | 2000 |
Inhibition of p450 17 as a new strategy for the treatment of prostate cancer.
Topics: Androgen Antagonists; Androstenes; Androstenols; Enzyme Inhibitors; Humans; Imidazoles; Inhibitory Concentration 50; Male; Molecular Structure; Prostatic Neoplasms; Steroid 17-alpha-Hydroxylase | 2005 |